Aggressive periodontitis (AgP) is featured of the rapid rate of disease progression, onset in healthy individuals without large accumulation of plaque and/or calculus, and with genetic familial trait[@b1][@b2][@b3]. In 1999, the new term "aggressive periodontitis" have been proposed to replace the former nomenclature "early-onset periodontitis", which contained "juvenile periodontitis", "rapidly progressive periodontitis", and "prepubertal periodontitis"[@b4]. Concerning the serious hazards of periodontal tissues of patients with AgP in adolescents, it has widely involved more and more scholars and etiological researches referred to the molecular biology, genetics, microbiology, cell biology and other fields for its complex etiology. Surely, some pathogens are the external initiating factor in the pathogenesis of AgP, and the degrees of harm risk are inconsistent, suggesting that host heterogeneity might be a decisive factor in the pathogenesis of AgP[@b5]. Hence, AgP can be considered as a complex genetic disease and the influence of genes and environmental factors determine the individual phenotype corporately[@b6].

With the deepen research of human gene, the more extensive evidence of pathogenesis of periodontitis has been provided[@b7]. Researches indicated nearly half of the clinical differences of periodontal disease rooted from gene polymorphism[@b8]. Therefore, many gene polymorphisms have been investigated[@b9][@b10][@b11][@b12][@b13]. Tumor necrosis factor (TNF) - α is one of the most potent proinflammatory cytokines and play a role in tissue injury and induced bone resorption in the immune response system, and its coding gene has been mapped to chromosome 6. The G-308A (rs1800629) is a polymorphism causing a substitution from the guanine (G) to adenine (A) and leads to two- to three fold higher transcriptional activity of TNF-α upon stimulation with bacterial lipopolysaccharide[@b14][@b15]. Carriage of the rare -308 A allele is associated with significantly greater TNF-α production and transcription. In addition, the A allele has been associated with increased risk for various non-related infectious and inflammatory diseases, including periodontitis.

In 2013, Song *et al.* performed a meta-analysis and indicated that TNF-a -308 A allele was associated with periodontitis[@b10]; However, their meta-analysis pooled chronic periodontitis (CP) and AgP together and included only 6 case-control studies for AgP. Nowadays, there were 17 studies that explored the association between TNF-α G-308A polymorphism and AgP have been published. The results of these published studies remain inconsistent. Therefore, this meta-analysis was conducted to provide an updated approach on the overall relationship between TNF-α G-308A polymorphism and AgP. Subgroup analyses were also performed on smoking and non-smoking status to investigate smoking-specific effects and cumulative analysis was used to investigate the trend of association.

Methods
=======

We followed the recommended Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement[@b16] to report this meta-analysis, and the ethnic review was not required.

Eligibility criteria
--------------------

According to the "PICOS" principle[@b16], this meta-analysis included studies which met the following criteria: (i) evaluating the association between TNF-α G-308A polymorphism and AgP, or all periodontitis but the data for AgP could be extracted; (ii) the study design was a case-control or cohort; (iii) the publication language was Chinese or English, and the full-text can be obtained; (iv) the relevant data was detailed enough to be used in the calculation, or the odds ratio (*OR*) with its 95% confidence interval (*CI*) was reported; (v) when more than one publications covered the same study population, we only included the study with higher quality and more comprehensive information. Animal experiments, conference abstracts, and comments were excluded. Studies with AgP patients who had any systematic diseases, such as diabetes mellitus, coronary heart disease were also excluded.

Search strategy
---------------

A systematical search to retrieve published literatures from PubMed, Embase, and CNKI (China Knowledge Resource Integrated) databases was conducted up to February 2, 2015. The following key words and subject terms were used: "tumor necrosis factor alpha", "TNF-α", "TNF-alpha", "periodontitis", "periodontal disease", "polymorphism", "mutation", and "variant". Hand-searching of listed references of included studies, previous meta-analysis, and recent reviews was also performed to identify additional studies.

Data extraction
---------------

The process of the data extraction was independently conducted and cross checked by two authors, and a third author participated in the discussion in case of divergence. We extracted the information as follows: the first author and year of publication, study area, ethnicity, smoking status, genotyping methods, the source of the controls, Hardy-Weinberg equilibrium (HWE) of control, and numbers of eligible genotyped cases and controls with the exhaustive data of each genotype distribution or the *OR* with its 95%*CI*.

Statistical analysis
--------------------

The *OR* with its 95% *CI* in the allelic contrast (A vs. G), recessive model (AA vs. AG+GG), dominant model (AA+AG vs. GG), and co-dominant model (AA vs. GG and AG vs. GG) were calculated to assess the association between TNF-α G-308A polymorphism and AgP risk. First, heterogeneity among included studies was detected using *I*^2^ and Cochran *Q* statistics, and the value of *I*^2^ ≤50% and *p* \> 0.1 indicates low heterogeneity and using fixed-effects model, otherwise the random-effects model is used[@b17][@b18][@b19][@b20]. We conducted stratification analyses on the bias of control conform to HWE, ethnicity, source of control, and smoking status. In order to investigate the robustness of overall analysis, we conducted sensitivity analysis by deleting each included study in turn[@b21][@b22][@b23]. The cumulative analysis was also carried out to explore the trend of association[@b24][@b25]. Moreover, we performed meta-regression to figure the influence of smoking status for TNF-α G-308A polymorphism and the susceptibility of AgP. Publication bias was analyzed by funnel plot and Egger's test[@b26]. All the above mentioned statistical analyses were undertaken using the Comprehensive Meta-Analysis v2.2 software[@b21][@b22][@b23].

Results
=======

Characteristics of included studies
-----------------------------------

A total of 194 citations was yielded and finally 16 case-control studies involving 905 cases and 1270 controls were included[@b27][@b28][@b29][@b30][@b31][@b32][@b33][@b34][@b35][@b36][@b37][@b38][@b39][@b40][@b41][@b42]. One was excluded due to the AgP patients with type 1 diabetes mellitus[@b43]. [Figure 1](#f1){ref-type="fig"} showed the process of study selection.

Seven studies both included smokers and non-smokers[@b30][@b31][@b33][@b34][@b35][@b37][@b41], six only included non-smokers[@b29][@b32][@b36][@b38][@b40][@b42], and three did not report smoking status[@b27][@b28][@b39]. One study only reported the *OR* and 95%*CI* of Allele comparison[@b39], the others all reported the genotyping distribution. The controls of two studies out of HWE[@b30][@b42]. Detailed information of characteristics of included studies is available in [Table 1](#t1){ref-type="table"}.

Overall, cumulative, and sensitivity analyses
---------------------------------------------

The overall analysis showed a significantly increased risk in A vs. G (*OR* = 1.23, 95%*CI* = 1.04--1.44; [Fig. 2](#f2){ref-type="fig"}), AA vs. GG (*OR* = 2.07, 95%*CI* = 1.11--3.87; see [Supplementary Fig. S1](#S1){ref-type="supplementary-material"} online), and AA vs. AG+GG genetic models (*OR* = 2.09, 95%*CI* = 1.13--3.86; see [Supplementary Fig. S2](#S1){ref-type="supplementary-material"} online); however, the non-significant increased risk was shown in AG vs. GG (*OR* = 1.06, 95%*CI* = 0.85--1.32; see [Supplementary Fig. S3](#S1){ref-type="supplementary-material"} online) and AA+AG vs. GG genetic models (*OR* = 1.06, 95%*CI* = 0.85--1.31; see [Supplementary Fig. S4](#S1){ref-type="supplementary-material"} online). The heterogeneity of all the five genetic models were acceptable and the results were pooled using fixed-effects model ([Table 2](#t2){ref-type="table"}).

The cumulative analysis was performed by accumulating included studies sequentially with increasing publication year, and the result showed that the association changed from non-significant to significant with new studies accumulated and the *CIs* became more and more narrow ([Fig. 3](#f3){ref-type="fig"}). The sensitivity analysis was performed by deleting every included studies of this meta-analysis one by one, the results were not materially altered that indicating our results were statistically robust ([Fig. 4](#f4){ref-type="fig"}).

Subgroups, meta-regression, and publication bias analyses
---------------------------------------------------------

[Table 2](#t2){ref-type="table"} showed the results of all performed subgroup analyses. Stratified analyses of confirmed of HWE, Asians, Caucasians, and population-based controls obtained results similar to that of the overall analysis; however, the results of out of HWE studies, hospital-based controls, mixed smoking status, non-smokers, Brazilians, and Chileans all revealed non-significant association between TNF-α G-308A polymorphism and AgP. The results of meta-regression analysis showed that the smoking status can't affect the association between TNF-α G-308A polymorphism and the susceptibility to AgP (see [Supplementary Fig. S5](#S1){ref-type="supplementary-material"} online).

Dependably, no evidence of publication bias was found in this meta-analysis for any genetic models, which was supported by Egger's test (A vs. G: *p* = 0.72; AA vs. GG: *p* = 0.99; AG vs. GG: *p* = 0.66; AA vs. AG+GG: *p* = 0.97; and AA+AG vs. GG: *p* = 0.25) and symmetric funnel plots ([Fig. 5](#f5){ref-type="fig"}).

Discussion
==========

Main findings
-------------

AgP, a distinguished subgroup of CP with the characteristics of familial aggregates, rapid disease progression and high incidence among period of adolescents, has a strong influence on the health of periodontal tissue. Epidemiologic studies showed that the incidence of AgP differed widely among different areas, different countries and different races. Unsatisfactorily, related reported dates were relative limited, ranging from 0.1% to 15% among overseas[@b44]. Now there are numerous studies on gene polymorphisms of inflammatory factor but haven't come to an accordant conclusion[@b45]. As the local inflammation of the body, inflammatory factor TNF-α has an important stimulation and has a wide biological effect on leukocytes, vascular endothelium cells and different cells in connective tissue. TNF-α can cause the destruction of connective tissue and strengthen the formation and activity of osteoclast, thereby limiting the repair of periodontal tissue[@b46]. Our meta-analysis with 16 case-control studies quantitatively explores the relationship between TNF-α G-308A polymorphism and the susceptibility to AgP, demonstrating that the TNF-α G-308A polymorphism confers a weak susceptibility to AgP, and sensitivity analyses showed the results were robust. Subgroups analyses showed that TNF-a G-308A polymorphism might be associated with Caucasian and Asians, but not associated with Brazilians and Chileans. The results of cumulative analysis showed that the association changed from non-significant to significant with new studies accumulated, and this might indicate that statistical significance could be detected when sample size became enough.

Considering smoking is responsible for periodontitis to some certain degree[@b47][@b48], we conducted a subgroup analysis based on smoking status. The results showed that the association between TNF-α G-308A polymorphism and the susceptibility to AgP was not affected by the smoking status in all contrast gene type, thus smoking status maybe not be a factors of special importance in TNF-α G-308A polymorphism, and this was also confirmed by meta-regression analysis. However, the results of HWE and source of controls indicated that studies out of HWE and studies with controls from hospital might bias the result.

Strengths of study
------------------

The previous meta-analysis by Song *et al.*[@b10] in 2013 investigated the TNF-α G-308A polymorphism and CP and AgP at the same time. This meta-analysis included 6 case-control studies for AgP and yielded negative association. Compared with CP, AgP refers to uncommon forms of bacterially-induced periodontitis and is considered as a genetically inherited disease[@b6][@b22][@b23][@b49]. Hence, our study is the first meta-analysis focusing on the association between TNF-α G-308A polymorphism and AgP risk. We also considered the influence of smoking status and stratified analysis according to the smoking status, which could provide more valuable information on this topic. Additionally, our meta-analysis included 16 case-control studies and the results are more precise, and the cumulative analyses also proved this. Moreover, we conducted four subgroups meta-analysis based on characteristics of studies and explained these roundly, while their just for race. Obviously, compared with this meta-analysis, our study carried out cumulative meta-analysis, smoking status based analysis and meta-regression analysis. Of course, our meta-analysis provided more advisory for periodontitis prevention, diagnosis, and treatment.

Our meta-analysis, conducted following a canonical systematically processes, for which some specific points need to be interpreted here. As we all know, the nomenclature of AgP has evolved with further understanding about the disease, but some researchers failed to capture the new terms in time, precisely, we not only took the present name "aggressive periodontitis, AgP" but also the former name "early-onset periodontitis, EOP" into account to ensure comprehensively covering eligible studies. The studies of Zhu *et al.* in 2007[@b33] compared the differences of gene polymorphisms between male and female and reached the conclusion that TNF-α G-308A might be associated with the susceptibility to AgP for male individuals in China, while other included studies did not implement analysis by gender, accordingly the factor of genders cannot be analyzed here, but may be of value.

Limitations of study
--------------------

Meta-analysis is a secondary research, and the result of its researches largely depended on primary studies[@b50], so there inevitably existed some limitations. First, 9 included studies were conducted based on Caucasian but for other races only 1 to 3 studies could be acquired, indicating limitations from the insufficient numbers of primary researches for some subgroups based on ethnicity; moreover, the sample sizes in some included studies, overall and subgroups analyses were relatively small. The limited sample sizes might bias the result. The cumulative analysis also indicated that the association became significant when the thirteen study accumulated. According to this, we must treat all results of subgroup analyses with caution. Second, it is hard for researchers to ensure strict consistency when they conduct research under the control of related factors criteria, such as age range, physical condition and lifestyle of the included populations, the diagnose index of AgP, the genotyping methods of included studies, which will affect the result of research to some degree. Of course, these are also the shortcomings of case-control study. Our meta-analysis based on case-control studies and did not escape from the influence of these factors. Third, publication bias test showed no evidence of publication bias existed, but this research conducted a comprehensive retrieval with language limited to Chinese and English, thus it may lead to the corresponding language bias, although we know this was limited by the accessibility to databases and ability of language. Fourth, the defect of a single gene may be a weak factor to promote the cause of disease directly for the normal function of proteins will not easily change that kind of greatly, so the combined polygenic factors are worth considering strengthening the evidence. Additionally, the adjusted data could not be extracted from included studies and we can only carry our analyses based on crude data. All in all, we should take the conclusion of this study seriously.

Implications for practice and research
--------------------------------------

From the foregoing, as for the association between TNF-α G-308A polymorphism and AgP susceptibility, large-scale and high-quality researches can be implemented in point. Owing to the complex causes of AgP alone with a wide range of risk of factors, such as individual immunity, special microbial infection, heredity, certain diseases (e.g. diabetes), gender, habits (e.g. smoking, diet), stress, certain genetic polymorphisms, etc, future researches should try to strictly control various confounding factors to ensure the reliability of the results with explicit and strict inclusion criteria of cases. Thus, there are some points we recommend for further practices and researches. As we know, smoking is a risk factor and influence the treatment effect of periodontitis[@b48][@b51], moreover, subgroup analysis and meta-regression analysis both indicated that this polymorphism was not influenced by smoking status ([Table 2](#t2){ref-type="table"} and see [Supplementary Fig. S5](#S1){ref-type="supplementary-material"} online). This might mean that we could not know whether TNF-α G-308A polymorphism is a marker of smoking rather or a risk factor of AgP susceptibility. Hence, what the role of TNF-α G-308A polymorphism in the development of AgP is necessary to research either in smokers or non-smokers. Large-scale studies combining multiple loci might be of significance; then, further investigations based on the difference between population characterizes, such as gender, age, family history, can be developed; furthermore, combining with other type diseases or risk factors facilitated to AgP to explore the susceptibility between gene polymorphisms and AgP with multiple dangerous risk factors may be an additional direction of research. Moreover, from the implications of subgroups analysis and cumulative analysis, more relevant studies should be performed due to the small sample size currently. We also suggest that further studies should provide adjusted data, use population-based design, use uniformed AgP diagnosis criteria, and clearly reported the smoking status and ethnicity.
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###### Characteristics of studies included in the meta-analysis.

  References         Country (ethnicity)   Smoking status   Genotyping method   Source of control   Case/ Control           HWE                   
  ----------------- --------------------- ---------------- ------------------- ------------------- --------------- ---------------------- ------- -----
  Endo 2001             Japan (Asian)         Unknown           PCR-SSOP               PB              46/104              90/204           2/4    Yes
  Shapira 2001       Israel (Caucasian)       Unknown          PCR-TaqMan              PB               16/27              29/47            3/7    Yes
  Pérez 2004          Chile (Chileans)      Non-smokers         PCR-RFLP               PB               27/30              49/55            5/5    Yes
  Brett 2005           UK (Caucasian)          Mixed             PCR-SSP               PB               50/97              76/155          24/39   No
  Sakellari 2006      Greek (Caucasian)        Mixed               PCR                 PB               46/90              78/156          14/24   Yes
  Zhu 2007              China (Asian)          Mixed            PCR-RFLP               HB               64/78             111/144          17/12   Yes
  de Freitas 2007    Brazil (Caucasian)     Non-smokers         PCR-RFLP               PB               30/70              46/102          14/38   Yes
  Guzeldemir 2008    Turkey (Caucasian)     Non-smokers            PCR                 PB               31/31              46/55           16/7    Yes
  Schulz 2008        Germany (Caucasian)       Mixed               PCR                 PB               69/52              109/86          29/18   Yes
  Menezes 2008       Brazil (Brazilian)        Mixed            PCR-RFLP               HB               38/51              61/73           15/29   Yes
  Moreira 2009       Brazil (Brazilian)        Mixed            PCR-RFLP               HB               55/43              95/72           15/14   Yes
  Erciyas 2010       Turkey (Caucasian)     Non-smokers          PCR-SSP               PB               35/85              55/154          15/16   Yes
  Scapoli 2011        Italy (Caucasian)       Unknown         PCR-MassARRAY            PB              122/246      1.19(0.81--1.74)^\*^           Yes
  Ebadian 2013       Iranian (Caucasian)    Non-smokers         PCR-RFLP               PB               58/60              74/88           42/32   Yes
  Yang 2013             China (Asian)          Mixed            PCR-RFLP               HB              180/180            275/292          85/68   Yes
  Özer Yücel 2015    Turkey (Caucasian)     Non-smokers         PCR-RFLP               HB               38/26              56/35           20/17   No

PB, population-based; HB, hospital-based; HWE, Hardy-Weinberg equilibrium; Mixed, smokers and non-smokers; \*odds ratio with its 95% confidence interval.

###### Results of overall and subgroups analyses.

  Overall and subgroups    Number of Studies   Heterogeneity   Model   Meta-analysis                     
  ----------------------- ------------------- --------------- ------- --------------- ------------------ ------
  **A vs. G**                     16               0.34        9.61        Fixed       1.23(1.04--1.44)   0.01
  HWE (Yes)                       14               0.32        12.35       Fixed       1.26(1.06--1.49)   0.01
  HWE (No)                         2               0.28        15.29       Fixed       1.04(0.65--1.65)   0.88
  Population-based                11               0.56          0         Fixed       1.31(1.07--1.61)   0.01
  Hospital-based                   5               0.14        41.6        Fixed       1.10(0.85--1.43)   0.47
  Smoking (Mixed)                  7               0.45          0         Fixed       1.19(0.95--1.48)   0.13
  Smoking (No)                     6               0.09        47.68      Random       1.39(0.88--2.17)   0.15
  Asian                            3               0.74          0         Fixed       1.39(1.01--1.92)   0.04
  Brazilian                        2               0.62          0         Fixed       0.70(0.40--1.18)   0.18
  Caucasian                        9                0.3        15.37       Fixed       1.27(1.04--1.55)   0.02
  Chileans                         1                 /           /           /         1.12(0.31--4.11)   0.86
  **AA vs. GG**                   15               0.14        36.5        Fixed       2.07(1.11--3.87)   0.02
  HWE (Yes)                       13               0.14        36.5        Fixed       2.07(1.11--3.87)   0.02
  HWE (No)                         2                --          --          --                --           --
  Population-based                10               0.27        22.38       Fixed       2.73(1.01--7.35)   0.05
  Hospital-based                   5               0.04        75.6       Random       1.15(0.17--7.87)   0.89
  Smoking (Mixed)                  7               0.11        50.97      Random       2.18(0.56--8.44)   0.26
  Smoking (No)                     6               0.18        38.63       Fixed       1.95(0.64--6.00)   0.24
  Asian                            3                 1           0         Fixed       2.71(1.09--6.73)   0.03
  Brazilian                        2                 1           0         Fixed       0.37(0.07--2.02)   0.25
  Caucasian                        9               0.27        22.38       Fixed       2.73(1.01--7.35)   0.05
  Chileans                         1                 /           /           /                --           --
  **AG vs. GG**                   15               0.22        20.56       Fixed       1.06(0.85--1.32)   0.62
  HWE (Yes)                       13                0.2        24.15       Fixed       1.06(0.83--1.34)   0.64
  HWE (No)                         2               0.18        44.51       Fixed       1.06(0.60--1.87)   0.85
  Population-based                10               0.19        28.16       Fixed       1.15(0.85--1.55)   0.35
  Hospital-based                   5               0.35        9.53        Fixed       0.96(0.69--1.32)   0.79
  Smoking (Mixed)                  7               0.56          0         Fixed       1.01(0.77--1.32)   0.96
  Smoking (No)                     6               0.04        57.69      Random       1.21(0.81--1.82)   0.34
  Asian                            3               0.32        12.67       Fixed       1.14(0.77--1.69)   0.52
  Brazilian                        2               0.92          0         Fixed       0.75(0.40--1.42)   0.38
  Caucasian                        9               0.08        42.99      Random       1.06(0.70--1.59)   0.79
  Chileans                         1                 /           /           /         1.14(0.29--4.45)   0.85
  **AA vs. AG+GG**                15               0.13        37.95       Fixed       2.09(1.13--3.86)   0.02
  HWE (Yes)                       13               0.13        37.95       Fixed       2.09(1.13--3.86)   0.02
  HWE (No)                         2                --          --          --                --           --
  Population-based                10               0.22        29.33       Fixed       2.65(0.99--7.04)   0.05
  Hospital-based                   5               0.05        73.93      Random       1.22(0.20--7.62)   0.83
  Smoking (Mixed)                  7               0.11        49.57       Fixed       2.20(1.05--4.61)   0.04
  Smoking (No)                     6               0.15        43.12       Fixed       1.86(0.62--5.63)   0.27
  Asian                            3                 1           0         Fixed       2.75(1.12--6.75)   0.03
  Brazilian                        2                 1           0         Fixed       0.42(0.08--2.19)   0.3
  Caucasian                        9               0.22        29.33       Fixed       2.65(0.99--7.04)   0.05
  Chileans                         1                 /           /           /                --           --
  **AA+AG vs. GG**                15               0.91          0         Fixed       1.06(0.85--1.31)   0.61
  HWE (Yes)                       13               0.93          0         Fixed       1.06(0.84--1.33)   0.64
  HWE (No)                         2               0.18        44.51       Fixed       1.06(0.60--1.87)   0.85
  Population-based                10               0.99          0         Fixed       1.08(0.80--1.45)   0.62
  Hospital-based                   5               0.24        26.65       Fixed       1.03(0.76--1.41)   0.84
  Smoking (Mixed)                  7               0.58          0         Fixed       1.10(0.85--1.43)   0.45
  Smoking (No)                     6               0.83          0         Fixed       0.98(0.65--1.46)   0.91
  Asian                            3               0.52          0         Fixed       1.29(0.89--1.88)   0.18
  Brazilian                        2               0.74          0         Fixed       0.70(0.38--1.30)   0.26
  Caucasian                        9               0.92          0         Fixed       1.02(0.76--1.37)   0.89
  Chileans                         1                 /           /         Fixed       1.14(0.29--4.45)   0.85

OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium; --, the AA frequency = 0; /, only one study included.

[^1]: These authors contributed equally to this work.
